


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 2 Apr 2007
FDA Approves Rhophylac(R) for the Treatment of Immune Thrombocytopenic Purpura (ITP)
FDA Approves Rhophylac(R) for the Treatment of Immune Thrombocytopenic Purpura (ITP)
HSMN NewsFeed - 2 Apr 2007
Affinium Pharmaceuticals Welcomes Dr. Barry Hafkin as Chief Medical Officer
Affinium Pharmaceuticals Welcomes Dr. Barry Hafkin as Chief Medical Officer
HSMN NewsFeed - 2 Apr 2007
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with IMPAX Laboratories
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with IMPAX Laboratories
HSMN NewsFeed - 2 Apr 2007
Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in Psoriasis
Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in Psoriasis
HSMN NewsFeed - 2 Apr 2007
IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
HSMN NewsFeed - 2 Apr 2007
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
HSMN NewsFeed - 2 Apr 2007
Encysive Pharmaceuticals Announces Launch of Thelin (Sitaxentan Sodium) in Republic of Ireland
Encysive Pharmaceuticals Announces Launch of Thelin (Sitaxentan Sodium) in Republic of Ireland
HSMN NewsFeed - 31 Mar 2007
Baxter Announces FDA Approval Of Ceprotin For Severe Congential Protein C Deficiency
Baxter Announces FDA Approval Of Ceprotin For Severe Congential Protein C Deficiency
HSMN NewsFeed - 30 Mar 2007
Study Suggests INVEGA(TM) Helps Patients With Schizophrenia Maintain Symptom Control
Study Suggests INVEGA(TM) Helps Patients With Schizophrenia Maintain Symptom Control
HSMN NewsFeed - 30 Mar 2007
Novartis Suspends US Marketing and Sales of Zelnorm(R) in Response to Request from FDA
Novartis Suspends US Marketing and Sales of Zelnorm(R) in Response to Request from FDA
HSMN NewsFeed - 29 Mar 2007
GlaxoSmithKline Submits Biologics License Application to U.S. Food and Drug Administration for CERVARIX(R)
GlaxoSmithKline Submits Biologics License Application to U.S. Food and Drug Administration for CERVARIX(R)
HSMN NewsFeed - 29 Mar 2007
Cameron Macdonald Appointed Managing Director of Controlled Therapeutics (Scotland) Limited
Cameron Macdonald Appointed Managing Director of Controlled Therapeutics (Scotland) Limited
HSMN NewsFeed - 29 Mar 2007
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
HSMN NewsFeed - 29 Mar 2007
Cobalis Locks Database for Pivotal Twin Phase III Trials of PreHistin(TM) in Seasonal Allergic Rhinitis
Cobalis Locks Database for Pivotal Twin Phase III Trials of PreHistin(TM) in Seasonal Allergic Rhinitis
HSMN NewsFeed - 28 Mar 2007
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data
HSMN NewsFeed - 27 Mar 2007
United Therapeutics and Mochida Pharmaceutical Sign Remodulin Distribution Agreement for Japan
United Therapeutics and Mochida Pharmaceutical Sign Remodulin Distribution Agreement for Japan
HSMN NewsFeed - 27 Mar 2007
Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
HSMN NewsFeed - 27 Mar 2007
Eve Slater to Resign From VaxGen's Board After Accepting Management Position at Leading Pharmaceutical Firm
Eve Slater to Resign From VaxGen's Board After Accepting Management Position at Leading Pharmaceutical Firm
HSMN NewsFeed - 27 Mar 2007
Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech
Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech
HSMN NewsFeed - 27 Mar 2007
Sapphire Therapeutics, Inc. Promotes William Polvino to CEO, Herb Conrad Elected Chairman of the Board
Sapphire Therapeutics, Inc. Promotes William Polvino to CEO, Herb Conrad Elected Chairman of the Board
HSMN NewsFeed - 27 Mar 2007
Adams Respiratory Therapeutics Enters Into License and Collaboration Agreement With MonoSol Rx, LLC
Adams Respiratory Therapeutics Enters Into License and Collaboration Agreement With MonoSol Rx, LLC
HSMN NewsFeed - 27 Mar 2007
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
HSMN NewsFeed - 27 Mar 2007
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Metastatic Brain Cancer
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Metastatic Brain Cancer
HSMN NewsFeed - 27 Mar 2007
MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
HSMN NewsFeed - 26 Mar 2007
Cephalon Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
Cephalon Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
HSMN NewsFeed - 26 Mar 2007
USDA Grants Conditional Approval for First Therapeutic Vaccine to Treat Cancer
USDA Grants Conditional Approval for First Therapeutic Vaccine to Treat Cancer
HSMN NewsFeed - 26 Mar 2007
Iroko Pharmaceuticals Acquires Rights to Two Pharmaceutical Products from Merck & Co., Inc.
Iroko Pharmaceuticals Acquires Rights to Two Pharmaceutical Products from Merck & Co., Inc.
HSMN NewsFeed - 26 Mar 2007
Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
HSMN NewsFeed - 26 Mar 2007
Enzastaurin Granted Orphan Drug Status for Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Enzastaurin Granted Orphan Drug Status for Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
HSMN NewsFeed - 26 Mar 2007
Merck and Schering-Plough to Develop Another New Cholesterol Lowering Medicine
Merck and Schering-Plough to Develop Another New Cholesterol Lowering Medicine
HSMN NewsFeed - 26 Mar 2007
Victory Pharma, Inc. Sales Force Expansion Signifies Growth of Its US Commercial Operations
Victory Pharma, Inc. Sales Force Expansion Signifies Growth of Its US Commercial Operations
HSMN NewsFeed - 26 Mar 2007
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
HSMN NewsFeed - 26 Mar 2007
ADVENTRX and TRx Pharma Announce Zanaflu(R) Registered as the Brand Name for ANX-211 (Chitosan Gel)
ADVENTRX and TRx Pharma Announce Zanaflu(R) Registered as the Brand Name for ANX-211 (Chitosan Gel)
HSMN NewsFeed - 26 Mar 2007
EpiCept Corporation Appoints Stephane Allard, M.D. as New Chief Medical Officer
EpiCept Corporation Appoints Stephane Allard, M.D. as New Chief Medical Officer
HSMN NewsFeed - 25 Mar 2007
First Study to Show Positive Benefit on Atherosclerosis for People With Early Signs of Diseased Arteries
First Study to Show Positive Benefit on Atherosclerosis for People With Early Signs of Diseased Arteries
HSMN NewsFeed - 25 Mar 2007
KAI Pharmaceuticals Presents Encouraging Phase 1/2 Results of a Novel Treatment for Heart Attack
KAI Pharmaceuticals Presents Encouraging Phase 1/2 Results of a Novel Treatment for Heart Attack
HSMN NewsFeed - 24 Mar 2007
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
HSMN NewsFeed - 23 Mar 2007
Pfizer Announces Launch of Generic Amlodipine Besylate Product by Greenstone
Pfizer Announces Launch of Generic Amlodipine Besylate Product by Greenstone
HSMN NewsFeed - 23 Mar 2007
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
HSMN NewsFeed - 23 Mar 2007
NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
HSMN NewsFeed - 23 Mar 2007
UCB Provides Update on CIMZIA(TM) for Crohn's Disease and Rheumatoid Arthritis in the US
UCB Provides Update on CIMZIA(TM) for Crohn's Disease and Rheumatoid Arthritis in the US
HSMN NewsFeed - 22 Mar 2007
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 22 Mar 2007
Pfizer Statement in Response to Appeals Court Decision in Norvasc Patent Case
Pfizer Statement in Response to Appeals Court Decision in Norvasc Patent Case
HSMN NewsFeed - 22 Mar 2007
Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacell's ONCONASE(R)
Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacell's ONCONASE(R)
HSMN NewsFeed - 22 Mar 2007
Cobalis Completes Funding; Expects Top-Line Phase III Trial Results for PreHistin(TM) in April 2007
Cobalis Completes Funding; Expects Top-Line Phase III Trial Results for PreHistin(TM) in April 2007
HSMN NewsFeed - 22 Mar 2007
Satraplatin Phase 3 SPARC Trial - Additional Data Presented at European Association of Urology Congress
Satraplatin Phase 3 SPARC Trial - Additional Data Presented at European Association of Urology Congress
HSMN NewsFeed - 22 Mar 2007
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
HSMN NewsFeed - 22 Mar 2007
CVS/Caremark Merger Closes, Creating the Nation's Leading Pharmacy Services Company
CVS/Caremark Merger Closes, Creating the Nation's Leading Pharmacy Services Company
HSMN NewsFeed - 22 Mar 2007
Lilly Announces Additional $50 Million Investment in Global Tuberculosis Partnership
Lilly Announces Additional $50 Million Investment in Global Tuberculosis Partnership
HSMN NewsFeed - 21 Mar 2007
Adams Respiratory Therapeutics Enters Into Settlement Agreement With Mutual Pharmaceutical
Adams Respiratory Therapeutics Enters Into Settlement Agreement With Mutual Pharmaceutical
HSMN NewsFeed - 21 Mar 2007
ADDERALL XR(R) - Shire Files Suit Against Colony Pharmaceuticals, Inc., Actavis, Inc. and Actavis Group hf
ADDERALL XR(R) - Shire Files Suit Against Colony Pharmaceuticals, Inc., Actavis, Inc. and Actavis Group hf
HSMN NewsFeed - 21 Mar 2007
Lexicon Genetics Appoints Tamar Howson Executive Vice President of Business Development
Lexicon Genetics Appoints Tamar Howson Executive Vice President of Business Development
HSMN NewsFeed - 20 Mar 2007
Idenix Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer
Idenix Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer
HSMN NewsFeed - 20 Mar 2007
Keppra(R) Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types
Keppra(R) Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types
HSMN NewsFeed - 20 Mar 2007
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
HSMN NewsFeed - 20 Mar 2007
Hospitals, Healthcare Providers to Save with Premier Pharmacy Physical Inventory Agreements
Hospitals, Healthcare Providers to Save with Premier Pharmacy Physical Inventory Agreements
HSMN NewsFeed - 20 Mar 2007
La Jolla Pharmaceutical Provides Update on Interim Antibody Results From Riquent(R) Lupus Phase 3 Trial
La Jolla Pharmaceutical Provides Update on Interim Antibody Results From Riquent(R) Lupus Phase 3 Trial
HSMN NewsFeed - 20 Mar 2007
Allos Therapeutics Appoints Pablo J. Cagnoni, M.D. as Chief Medical Officer
Allos Therapeutics Appoints Pablo J. Cagnoni, M.D. as Chief Medical Officer
HSMN NewsFeed - 20 Mar 2007
Myriad Genetics Completes Enrollment in Second Phase 3 Clinical Trial of Flurizan(TM) in Alzheimer's Disease
Myriad Genetics Completes Enrollment in Second Phase 3 Clinical Trial of Flurizan(TM) in Alzheimer's Disease
HSMN NewsFeed - 19 Mar 2007
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
HSMN NewsFeed - 19 Mar 2007
Auriga Laboratories Sales Force Doubles Again to 200 Associates since January
Auriga Laboratories Sales Force Doubles Again to 200 Associates since January
HSMN NewsFeed - 19 Mar 2007
Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for Vascugel(TM)
Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for Vascugel(TM)
HSMN NewsFeed - 19 Mar 2007
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
HSMN NewsFeed - 16 Mar 2007
Diffusion Pharmaceuticals Initiates Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
Diffusion Pharmaceuticals Initiates Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
HSMN NewsFeed - 16 Mar 2007
Endo and Vernalis plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA
Endo and Vernalis plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA
HSMN NewsFeed - 15 Mar 2007
Alliance Pharmaceutical Corp. Updates Clinical Development of Oxygent(TM) in China
Alliance Pharmaceutical Corp. Updates Clinical Development of Oxygent(TM) in China
HSMN NewsFeed - 15 Mar 2007
Trimeris and Roche Amend Research Agreement Covering Next-Generation HIV Fusion Inhibitors
Trimeris and Roche Amend Research Agreement Covering Next-Generation HIV Fusion Inhibitors
HSMN NewsFeed - 14 Mar 2007
Novavax Appoints James Robinson Vice President of Technical and Quality Operations
Novavax Appoints James Robinson Vice President of Technical and Quality Operations
HSMN NewsFeed - 14 Mar 2007
Tragara Pharmaceuticals, Inc. Announces Corporate Launch and Series A Financing
Tragara Pharmaceuticals, Inc. Announces Corporate Launch and Series A Financing
HSMN NewsFeed - 14 Mar 2007
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
HSMN NewsFeed - 14 Mar 2007
JACC Publishes Long-Term Safety and Tolerability Data from Ranolazine Open Label Experience (ROLE) Program
JACC Publishes Long-Term Safety and Tolerability Data from Ranolazine Open Label Experience (ROLE) Program
HSMN NewsFeed - 14 Mar 2007
Critical Therapeutics and DEY, L.P. Enter into Co-Promotion Agreement for Respiratory Care Products
Critical Therapeutics and DEY, L.P. Enter into Co-Promotion Agreement for Respiratory Care Products
HSMN NewsFeed - 14 Mar 2007
Napo Obtains IRB Approval for Phase 3 Clinical Trial Protocol for Crofelemer In HIV/AIDS Diarrhea Assessment
Napo Obtains IRB Approval for Phase 3 Clinical Trial Protocol for Crofelemer In HIV/AIDS Diarrhea Assessment
HSMN NewsFeed - 13 Mar 2007
GlaxoSmithKline Announces Expansion of Patient Assistance Program to Include TYKERB(R)
GlaxoSmithKline Announces Expansion of Patient Assistance Program to Include TYKERB(R)
HSMN NewsFeed - 13 Mar 2007
Kedrion and ProMetic Form Strategic Alliance to Develop Orphan Drugs from Plasma
Kedrion and ProMetic Form Strategic Alliance to Develop Orphan Drugs from Plasma
HSMN NewsFeed - 13 Mar 2007
GTC Biotherapeutics Grants Expanded License to PharmAthene for Further Development of Protexia(R)
GTC Biotherapeutics Grants Expanded License to PharmAthene for Further Development of Protexia(R)
HSMN NewsFeed - 13 Mar 2007
Xytis Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
Xytis Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
HSMN NewsFeed - 12 Mar 2007
New European Approval for Xyrem(R) Provides Significant Advance in the Treatment of Narcolepsy
New European Approval for Xyrem(R) Provides Significant Advance in the Treatment of Narcolepsy
HSMN NewsFeed - 12 Mar 2007
Cangene receives an approvable letter from the FDA for human growth hormone
Cangene receives an approvable letter from the FDA for human growth hormone
HSMN NewsFeed - 12 Mar 2007
Cytochroma appoints co-founder Dr. P. Martin Petkovich as full-time Chief Scientific Officer
Cytochroma appoints co-founder Dr. P. Martin Petkovich as full-time Chief Scientific Officer
HSMN NewsFeed - 12 Mar 2007
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
HSMN NewsFeed - 9 Mar 2007
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa)
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa)
HSMN NewsFeed - 9 Mar 2007
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
HSMN NewsFeed - 8 Mar 2007
Melvin Sharoky Elected to Board of Directors of Par Pharmaceutical Companies, Inc.
Melvin Sharoky Elected to Board of Directors of Par Pharmaceutical Companies, Inc.
HSMN NewsFeed - 8 Mar 2007
Astion Pharma Prepares Management Structure for Bringing Pharmaceuticals to Market
Astion Pharma Prepares Management Structure for Bringing Pharmaceuticals to Market
HSMN NewsFeed - 8 Mar 2007
CytRx RNAi Subsidiary, RXi Pharmaceuticals, Names Vice President of Pharmaceutical Development
CytRx RNAi Subsidiary, RXi Pharmaceuticals, Names Vice President of Pharmaceutical Development
HSMN NewsFeed - 8 Mar 2007
La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent(R) Lupus Phase 3 Trial
La Jolla Pharmaceutical Announces Positive Interim Antibody Results From Riquent(R) Lupus Phase 3 Trial
HSMN NewsFeed - 8 Mar 2007
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa(TM) in Brain Cancer
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa(TM) in Brain Cancer
HSMN NewsFeed - 8 Mar 2007
Barrier Therapeutics Receives Regulatory Approval to Market Xolegel(TM) in Canada
Barrier Therapeutics Receives Regulatory Approval to Market Xolegel(TM) in Canada
HSMN NewsFeed - 7 Mar 2007
Nuvo announces further update on discussions with the FDA related to review of Pennsaid
Nuvo announces further update on discussions with the FDA related to review of Pennsaid
HSMN NewsFeed - 7 Mar 2007
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
HSMN NewsFeed - 7 Mar 2007
The University of Texas Licenses Drug Delivery Technology to Newly Formed Mimetic Solutions, LLC
The University of Texas Licenses Drug Delivery Technology to Newly Formed Mimetic Solutions, LLC
HSMN NewsFeed - 7 Mar 2007
Authentix(R) Partners with AstraZeneca to Protect Drug Supply with Unit-Level Mass Serialisation
Authentix(R) Partners with AstraZeneca to Protect Drug Supply with Unit-Level Mass Serialisation
HSMN NewsFeed - 7 Mar 2007
Angiotech appoints Victor Diaz as Senior Vice President, Global Manufacturing & Supply Chain Management
Angiotech appoints Victor Diaz as Senior Vice President, Global Manufacturing & Supply Chain Management
HSMN NewsFeed - 6 Mar 2007
Oncologic Appoints Stephen T. Isaacs as President and Chief Executive Officer
Oncologic Appoints Stephen T. Isaacs as President and Chief Executive Officer
HSMN NewsFeed - 6 Mar 2007
Jury Finds in Favor of ETHEX/KV on All Claims Against KV Pharmaceutical and ETHEX Subsidiary
Jury Finds in Favor of ETHEX/KV on All Claims Against KV Pharmaceutical and ETHEX Subsidiary
HSMN NewsFeed - 6 Mar 2007
Perrigo Company to Acquire Generic Dermatological Products From Glades Pharmaceuticals
Perrigo Company to Acquire Generic Dermatological Products From Glades Pharmaceuticals
HSMN NewsFeed - 6 Mar 2007
Applied NeuroSolutions Hires Top Ranked Analyst, Ryan Rauch, to Direct its Investor Relations Program
Applied NeuroSolutions Hires Top Ranked Analyst, Ryan Rauch, to Direct its Investor Relations Program
HSMN NewsFeed - 5 Mar 2007
InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
HSMN NewsFeed - 5 Mar 2007
Amicus Therapeutics Announces Return of John F. Crowley as President and Chief Executive Officer
Amicus Therapeutics Announces Return of John F. Crowley as President and Chief Executive Officer
HSMN NewsFeed - 5 Mar 2007
Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies
Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies
HSMN NewsFeed - 5 Mar 2007
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
HSMN NewsFeed - 5 Mar 2007
Myriad Presents Additional Flurizan(TM) Phase 2 Study Data Demonstrating Benefit in Alzheimer's Patients
Myriad Presents Additional Flurizan(TM) Phase 2 Study Data Demonstrating Benefit in Alzheimer's Patients
HSMN NewsFeed - 2 Mar 2007
FDA Approves Astellas' Vaprisol(R) for the Treatment of Hypervolemic Hyponatremia
FDA Approves Astellas' Vaprisol(R) for the Treatment of Hypervolemic Hyponatremia
HSMN NewsFeed - 28 Feb 2007
King Pharmaceuticals Announces FDA Approval of ALTACE(R) Tablet Formulation
King Pharmaceuticals Announces FDA Approval of ALTACE(R) Tablet Formulation
HSMN NewsFeed - 28 Feb 2007
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
HSMN NewsFeed - 28 Feb 2007
Tercica Announces the Appointment of Richard A. King as Chief Operating Officer
Tercica Announces the Appointment of Richard A. King as Chief Operating Officer
HSMN NewsFeed - 28 Feb 2007
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
HSMN NewsFeed - 27 Feb 2007
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease
HSMN NewsFeed - 27 Feb 2007
Targeted Genetics Responds to Litigation Release SEC V. Crestview Capital Partners, LLC and Stewart R. Flink
Targeted Genetics Responds to Litigation Release SEC V. Crestview Capital Partners, LLC and Stewart R. Flink
HSMN NewsFeed - 27 Feb 2007
Auriga Settles Lawsuit to Reduce Royalties Payable on Levall Product Line by Approximately $10 Million
Auriga Settles Lawsuit to Reduce Royalties Payable on Levall Product Line by Approximately $10 Million
HSMN NewsFeed - 27 Feb 2007
Vaccinex Announces Antibody Development and Commercialization Alliance in Multiple Sclerosis and Oncology
Vaccinex Announces Antibody Development and Commercialization Alliance in Multiple Sclerosis and Oncology
HSMN NewsFeed - 27 Feb 2007
Initiation of Phase III Program Using Emisphere's eligen(R) Technology for Oral Salmon Calcitonin
Initiation of Phase III Program Using Emisphere's eligen(R) Technology for Oral Salmon Calcitonin
HSMN NewsFeed - 26 Feb 2007
Trius Therapeutics Enters into License Agreement with Dong-A Pharmaceuticals for Novel Anti-bacterial Agent
Trius Therapeutics Enters into License Agreement with Dong-A Pharmaceuticals for Novel Anti-bacterial Agent
HSMN NewsFeed - 26 Feb 2007
Trius Therapeutics Completes $20 Million Series A Financing and Names CEO
Trius Therapeutics Completes $20 Million Series A Financing and Names CEO
HSMN NewsFeed - 26 Feb 2007
VGX Pharmaceuticals and ADViSYS Announce Merger Agreement: Creation of VGX Immune Therapeutics Division
VGX Pharmaceuticals and ADViSYS Announce Merger Agreement: Creation of VGX Immune Therapeutics Division
HSMN NewsFeed - 26 Feb 2007
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
HSMN NewsFeed - 26 Feb 2007
INEX Provides Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation
INEX Provides Timeline for Completing Spin-out of Tekmira Pharmaceuticals Corporation
HSMN NewsFeed - 26 Feb 2007
GSK Initiates First Global Phase III Study of TYKERB(R) (lapatinib) in Head and Neck Cancer
GSK Initiates First Global Phase III Study of TYKERB(R) (lapatinib) in Head and Neck Cancer
HSMN NewsFeed - 26 Feb 2007
First patient enrolled in Stimuvax(R) Phase III clinical trial in patients with non-small cell lung cancer
First patient enrolled in Stimuvax(R) Phase III clinical trial in patients with non-small cell lung cancer
HSMN NewsFeed - 26 Feb 2007
Novelix Announces Licensing of Cancer Compound to AOP Orphan Pharmaceuticals
Novelix Announces Licensing of Cancer Compound to AOP Orphan Pharmaceuticals
HSMN NewsFeed - 26 Feb 2007
United Therapeutics Announces Pulmonary Hypertension Opinion Leaders' Guidance On Intravenous Therapies
United Therapeutics Announces Pulmonary Hypertension Opinion Leaders' Guidance On Intravenous Therapies
HSMN NewsFeed - 26 Feb 2007
Ipsen: Appointment of Stephane Thiroloix as Executive Vice-President, Corporate Development
Ipsen: Appointment of Stephane Thiroloix as Executive Vice-President, Corporate Development
HSMN NewsFeed - 23 Feb 2007
Phase 2 Results of Genasense(R) Plus Chemotherapy in Advanced Prostate Cancer Reported at Cancer Conference
Phase 2 Results of Genasense(R) Plus Chemotherapy in Advanced Prostate Cancer Reported at Cancer Conference
HSMN NewsFeed - 23 Feb 2007
Pfizer Board of Directors Elects Constance J. Horner to Serve as Lead Director
Pfizer Board of Directors Elects Constance J. Horner to Serve as Lead Director
HSMN NewsFeed - 23 Feb 2007
Dynavax Reports Interim, One-Year Data From Ragweed Allergy Trial at AAAAI
Dynavax Reports Interim, One-Year Data From Ragweed Allergy Trial at AAAAI
HSMN NewsFeed - 23 Feb 2007
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product
HSMN NewsFeed - 22 Feb 2007
New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets
New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets
HSMN NewsFeed - 22 Feb 2007
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
HSMN NewsFeed - 21 Feb 2007
Javelin Pharmaceuticals Names Derek Gallacher as European Managing Director
Javelin Pharmaceuticals Names Derek Gallacher as European Managing Director
HSMN NewsFeed - 21 Feb 2007
Access Pharmaceuticals Signs Letter of Intent to Acquire Somanta Pharmaceuticals
Access Pharmaceuticals Signs Letter of Intent to Acquire Somanta Pharmaceuticals
HSMN NewsFeed - 21 Feb 2007
Protalex Appoints Edward W. Bernton, MD as Medical Director and Updates Development Plans for 2007
Protalex Appoints Edward W. Bernton, MD as Medical Director and Updates Development Plans for 2007
HSMN NewsFeed - 21 Feb 2007
OncoMed Appoints Steven E. Benner, M.D., Senior Vice President and Chief Medical Officer
OncoMed Appoints Steven E. Benner, M.D., Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 21 Feb 2007
Idera Pharmaceuticals Appoints Dr. Alice Bexon, Vice President of Clinical Development
Idera Pharmaceuticals Appoints Dr. Alice Bexon, Vice President of Clinical Development
HSMN NewsFeed - 21 Feb 2007
King Pharmaceuticals Announces FDA Approval of New Bicillin(R) Manufacturing Facility
King Pharmaceuticals Announces FDA Approval of New Bicillin(R) Manufacturing Facility
HSMN NewsFeed - 21 Feb 2007
Maxygen Appoints Santosh Vetticaden, M.D., Ph.D., as Chief Medical Officer
Maxygen Appoints Santosh Vetticaden, M.D., Ph.D., as Chief Medical Officer
HSMN NewsFeed - 21 Feb 2007
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
HSMN NewsFeed - 21 Feb 2007
GPC Biotech Launches Expanded Access Program for Oncology Drug Candidate Satraplatin in the U.S.
GPC Biotech Launches Expanded Access Program for Oncology Drug Candidate Satraplatin in the U.S.
HSMN NewsFeed - 20 Feb 2007
NovaDel Comments on Delay in Zensana(TM) Launch, as Announced by Hana BioSciences
NovaDel Comments on Delay in Zensana(TM) Launch, as Announced by Hana BioSciences
HSMN NewsFeed - 20 Feb 2007
Neurocrine Biosciences Announces the Resignation of Adrian Adams From the Board of Directors
Neurocrine Biosciences Announces the Resignation of Adrian Adams From the Board of Directors
HSMN NewsFeed - 20 Feb 2007
Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
HSMN NewsFeed - 20 Feb 2007
Gerard McGarrity Joins VIRxSYS as Executive Vice President of Scientific and Clinical Affairs
Gerard McGarrity Joins VIRxSYS as Executive Vice President of Scientific and Clinical Affairs
HSMN NewsFeed - 20 Feb 2007
Gloucester Pharmaceuticals Appoints Pharmaceutical Veteran, Donald Hayden, as Vice-Chairman
Gloucester Pharmaceuticals Appoints Pharmaceutical Veteran, Donald Hayden, as Vice-Chairman
HSMN NewsFeed - 20 Feb 2007
Tapestry Pharmaceuticals Appoints Sandra L. Silberman, M.D., Ph.D. As Chief Medical Officer
Tapestry Pharmaceuticals Appoints Sandra L. Silberman, M.D., Ph.D. As Chief Medical Officer
HSMN NewsFeed - 20 Feb 2007
Shire Agrees to Acquire New River to Gain Full Control of VYVANSE(TM), its Future Flagship Product for ADHD
Shire Agrees to Acquire New River to Gain Full Control of VYVANSE(TM), its Future Flagship Product for ADHD
HSMN NewsFeed - 19 Feb 2007
LifeCycle Pharma Appoints Senior Vice President of Pharmaceutical Development
LifeCycle Pharma Appoints Senior Vice President of Pharmaceutical Development
HSMN NewsFeed - 16 Feb 2007
GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS
GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS
HSMN NewsFeed - 16 Feb 2007
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
HSMN NewsFeed - 16 Feb 2007
Anti-HIV Medication PREZISTA(TM) Receives Conditional Marketing Authorisation in the European Union
Anti-HIV Medication PREZISTA(TM) Receives Conditional Marketing Authorisation in the European Union
HSMN NewsFeed - 15 Feb 2007
INNOVIVE Pharmaceuticals Appoints Angelo De Caro to Its Board of Directors and Audit Committee
INNOVIVE Pharmaceuticals Appoints Angelo De Caro to Its Board of Directors and Audit Committee
HSMN NewsFeed - 15 Feb 2007
Valeant Pharmaceuticals Acquires Rights to Nabilone in United Kingdom and Europe
Valeant Pharmaceuticals Acquires Rights to Nabilone in United Kingdom and Europe
HSMN NewsFeed - 15 Feb 2007
Advanced Magnetics Announces Settlement of Lawsuit with Cytogen Corporation
Advanced Magnetics Announces Settlement of Lawsuit with Cytogen Corporation
HSMN NewsFeed - 15 Feb 2007
Bristol-Myers Squibb Names Sandra Leung Senior Vice President and General Counsel
Bristol-Myers Squibb Names Sandra Leung Senior Vice President and General Counsel
HSMN NewsFeed - 15 Feb 2007
FDA Accepts Two Supplemental New Drug Applications to Expand the U.S. Labeling for JANUVIA(TM)
FDA Accepts Two Supplemental New Drug Applications to Expand the U.S. Labeling for JANUVIA(TM)
HSMN NewsFeed - 14 Feb 2007
Light Sciences Oncology Initiates Phase II Trial of Litx(TM) Therapy in Patients with Glioma
Light Sciences Oncology Initiates Phase II Trial of Litx(TM) Therapy in Patients with Glioma
HSMN NewsFeed - 13 Feb 2007
Advancis Pharmaceutical Announces FDA Decision That its Amoxicillin PULSYS NDA is Not Complete
Advancis Pharmaceutical Announces FDA Decision That its Amoxicillin PULSYS NDA is Not Complete
HSMN NewsFeed - 13 Feb 2007
Seattle Genetics Receives Orphan Drug Designations for its SGN-33 and SGN-35 Programs
Seattle Genetics Receives Orphan Drug Designations for its SGN-33 and SGN-35 Programs
HSMN NewsFeed - 13 Feb 2007
MGI PHARMA and HELSINN HEALTHCARE SA Announce Patent Extension for Aloxi(R) Injection
MGI PHARMA and HELSINN HEALTHCARE SA Announce Patent Extension for Aloxi(R) Injection
HSMN NewsFeed - 13 Feb 2007
Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe
Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe
HSMN NewsFeed - 12 Feb 2007
AVANIR Pharmaceuticals Hires Martin J. Sturgeon as Vice President and Chief Accounting Officer
AVANIR Pharmaceuticals Hires Martin J. Sturgeon as Vice President and Chief Accounting Officer
HSMN NewsFeed - 12 Feb 2007
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
HSMN NewsFeed - 12 Feb 2007
Benda Pharmaceutical, Inc. Appoints Eric Yu Tak Shing as Its Chief Financial Officer
Benda Pharmaceutical, Inc. Appoints Eric Yu Tak Shing as Its Chief Financial Officer
HSMN NewsFeed - 12 Feb 2007
AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
HSMN NewsFeed - 12 Feb 2007
Morphotek Obtains Exclusive License from Micromet for Antibody to Treat Melanoma and Other Cancers
Morphotek Obtains Exclusive License from Micromet for Antibody to Treat Melanoma and Other Cancers
HSMN NewsFeed - 12 Feb 2007
Depomed and Biovail Sign License Agreement for AcuForm(TM) Drug Delivery Technology
Depomed and Biovail Sign License Agreement for AcuForm(TM) Drug Delivery Technology
HSMN NewsFeed - 12 Feb 2007
Nexavar Shown to Significantly Extend Survival for Patients with Advanced Liver Cancer
Nexavar Shown to Significantly Extend Survival for Patients with Advanced Liver Cancer
HSMN NewsFeed - 11 Feb 2007
Shlomo Yanai Will Assume the Role of Teva's President& CEO on March 1st, 2007
Shlomo Yanai Will Assume the Role of Teva's President& CEO on March 1st, 2007
HSMN NewsFeed - 8 Feb 2007
Cold Spring Harbor Laboratory Scientists Discover New Gene that Prevents Multiple Types of Cancer
Cold Spring Harbor Laboratory Scientists Discover New Gene that Prevents Multiple Types of Cancer
HSMN NewsFeed - 8 Feb 2007
Pfizer's Sutent Receives FDA Approval to Include New First-Line Advanced Kidney Cancer Data in Label
Pfizer's Sutent Receives FDA Approval to Include New First-Line Advanced Kidney Cancer Data in Label
HSMN NewsFeed - 8 Feb 2007
Access Pharmaceuticals Appoints Esteban Cvitkovic, M.D. as Director and Vice Chairman (Europe)
Access Pharmaceuticals Appoints Esteban Cvitkovic, M.D. as Director and Vice Chairman (Europe)
HSMN NewsFeed - 8 Feb 2007
Lundbeck USA Signs Lease Agreement to Establish U.S. Headquarters in King of Prussia, Pennsylvania
Lundbeck USA Signs Lease Agreement to Establish U.S. Headquarters in King of Prussia, Pennsylvania
HSMN NewsFeed - 8 Feb 2007
Polyanalgesic Consensus Panel Issues New Guidelines for Pain Management via Intraspinal Infusion
Polyanalgesic Consensus Panel Issues New Guidelines for Pain Management via Intraspinal Infusion
HSMN NewsFeed - 8 Feb 2007
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
HSMN NewsFeed - 8 Feb 2007
GlaxoSmithKline and XenoPort Announce Agreement on Late-Stage Compound for RLS and Neuropathic Pain
GlaxoSmithKline and XenoPort Announce Agreement on Late-Stage Compound for RLS and Neuropathic Pain
HSMN NewsFeed - 7 Feb 2007
Anavex Life Sciences Corp. Appoints VP Business Development and VP Strategic Planning
Anavex Life Sciences Corp. Appoints VP Business Development and VP Strategic Planning
HSMN NewsFeed - 7 Feb 2007
Biogen Idec Initiates Randomized, Registrational Trial of Lumiliximab for Chronic Lymphocytic Leukemia
Biogen Idec Initiates Randomized, Registrational Trial of Lumiliximab for Chronic Lymphocytic Leukemia
HSMN NewsFeed - 7 Feb 2007
Dr. David D. Waters Joins Anthera Pharmaceuticals as Cardiovascular Research Fellow
Dr. David D. Waters Joins Anthera Pharmaceuticals as Cardiovascular Research Fellow
HSMN NewsFeed - 6 Feb 2007
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
HSMN NewsFeed - 6 Feb 2007
Alliance Pharmaceutical Corp. Completes the Manufacture of Oxygent (TM) for Clinical Trials
Alliance Pharmaceutical Corp. Completes the Manufacture of Oxygent (TM) for Clinical Trials
HSMN NewsFeed - 6 Feb 2007
AtheroGenics Announces Promotion of Charles A. Deignan to Vice President of Finance and Administration
AtheroGenics Announces Promotion of Charles A. Deignan to Vice President of Finance and Administration
HSMN NewsFeed - 6 Feb 2007
Tim Rothwell Appointed Chairman of Sanofi-aventis Group U.S. Pharmaceutical Activities
Tim Rothwell Appointed Chairman of Sanofi-aventis Group U.S. Pharmaceutical Activities
